An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses.
Saved in:
| Title: | An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses. |
|---|---|
| Authors: | Ramesh AK; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Sivaccumar JP; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Zhejiang Key Laboratory of Multi-Omics in Infection and Immunity, Center for Infectious Disease Research, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China., Yang L; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA., Guo H; IGM Biosciences Inc., Mountain View, CA, USA., Chin CN; IGM Biosciences Inc., Mountain View, CA, USA., Ha S; IGM Biosciences Inc., Mountain View, CA, USA., Shiver JW; IGM Biosciences Inc., Mountain View, CA, USA., Strohl WR; IGM Biosciences Inc., Mountain View, CA, USA., Xu Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Du H; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Zhou T; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Xu K; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. xu.4692@osu.edu.; Department of Microbial Infection and Immunity & Veterinary Biosciences, Ohio State University, Columbus, OH, USA. xu.4692@osu.edu., Liu X; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA. xliu65@central.uh.edu., Fu TM; IGM Biosciences Inc., Mountain View, CA, USA. tong-ming_fu@hotmail.com., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA. zhiqiang.an@uth.tmc.edu. |
| Source: | Nature communications [Nat Commun] 2025 Apr 29; Vol. 16 (1), pp. 4025. Date of Electronic Publication: 2025 Apr 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-59294-0 |
